Top compounds associated with response to ZBTB7C


Feature Type Standardized
Nominal ANOVA
mRNA navitoclax:sorafenib (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.12 0.001
mRNA MK-2206 GDSC1000 pan-cancer AAC 0.12 0.001
mRNA doxorubicin:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.11 0.001
mRNA BRD-K41597374 CTRPv2 pan-cancer AAC 0.12 0.001
mRNA Mitomycin-C CTRPv2 pan-cancer AAC 0.11 0.001
mRNA Obatoclax Mesylate GDSC1000 pan-cancer AAC -0.11 0.001
mRNA BRD-K28456706 CTRPv2 pan-cancer AAC 0.12 0.001
mRNA thapsigargin GDSC1000 pan-cancer AAC -0.11 0.001
mRNA Doxorubicin gCSI pan-cancer AAC -0.17 0.001
mRNA cimetidine CTRPv2 pan-cancer AAC 0.22 0.001
Download CSV